RxDoctor Payments Data

James Fox, PA

Physician Assistant · Claremont, NCNPI 1730115718

Payments from drug & device makers

$5,276in general payments, 2019–2025

Across 323 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$928
  • AstraZeneca$643
  • Novo Nordisk$618
  • Lilly USA, LLC$451
  • Pfizer$416
  • Bayer$223
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$5,276100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,276 in reported general payments places this provider in the 90th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,898
Medicare patients
58
Services billed
108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide144$197,776
EliquisApixaban115$117,446
JardianceEmpagliflozin95$105,050
MounjaroTirzepatide71$83,642
Tresiba Flextouch U-200Insulin Degludec33$55,051
LinzessLinaclotide54$45,910
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$41,983
Tresiba Flextouch U-100Insulin Degludec21$28,769
FarxigaDapagliflozin Propanediol22$24,367
TrulicityDulaglutide16$23,842
JanuviaSitagliptin Phosphate24$22,722
VascepaIcosapent Ethyl37$21,485
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr38$21,239
JanumetSitagliptin Phos/Metformin Hcl24$19,953
Breztri AerosphereBudesonide/Glycopyr/Formoterol31$19,654

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$618$213,812161 claims
PfizerEliquis$416$117,446115 claims
Lilly USA, LLCMounjaro, Trulicity$451$107,48587 claims
Boehringer IngelheimJardiance$210$105,05095 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$170$68,809101 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Bevespi Aerosphere$643$62,54298 claims
AbbVieLinzess$928$45,91054 claims
MerckJanuvia, Janumet$25$42,67448 claims
Johnson & JohnsonXarelto$55$19,08619 claims
Otsuka America Pharmaceutical, Inc.Rexulti$104$18,64613 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$78$10,83216 claims
ANI Pharmaceuticals, Inc.Valsartan$30$2,138122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Claremont

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →